
China’s Duality Biotherapeutics launches $200m Hong Kong IPO
Chinese biotech firm Duality Biotherapeutics launched an initial public offering (IPO) of up to HK$1.56 billion ($200.7 million) on Monday in Hong Kong, testing investor appetite amid a global stock market rout. The company is selling 15.07 million shares …